News
RMD
263.54
-4.50%
-12.42
ResMed Inc. Stock Falls 4.5%, Underperforms Market
Dow Jones · 13h ago
Top Stock Reports for NVIDIA, Amazon & Regeneron
NASDAQ · 14h ago
Ex-Dividend Reminder: TJX Companies, UNITIL and ResMed
NASDAQ · 20h ago
Zacks.com featured highlights include Amphenol, GE Aerospace, ResMed and Ameriprise Financial
NASDAQ · 1d ago
Weekly Report: what happened at RMD last week (0202-0206)?
Weekly Report · 2d ago
ResMed (RMD) Is Up 5.2% After Strong Quarter, Dividend Hike And Completed Buyback Program
Simply Wall St · 2d ago
The Week That Was, The Week Ahead: Macro and Markets, Feb. 8
TipRanks · 3d ago
Why You Might Be Interested In ResMed Inc. (NYSE:RMD) For Its Upcoming Dividend
Simply Wall St · 3d ago
Dividend Champion, Contender, And Challenger Highlights: Week Of February 8
Seeking Alpha · 4d ago
Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR), Resmed (RMD) and Bristol-Myers Squibb (BMY)
TipRanks · 4d ago
ResMed Builds Digital Sleep Apnea Ecosystem As Investors Track Valuation
Simply Wall St · 6d ago
The Top 5 Analyst Questions From ResMed’s Q4 Earnings Call
Barchart · 6d ago
Top 50 High-Quality Dividend Growth Stocks For February 2026
Seeking Alpha · 6d ago
RMD Makes Bullish Cross Above Critical Moving Average
NASDAQ · 6d ago
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Gets a Buy from UBS
TipRanks · 02/04 07:46
ResMed At Wearable And AI Turning Point In Sleep Apnea Care
Simply Wall St · 02/04 02:33
Zacks Industry Outlook Highlights Boston Scientific, ResMed, Phibro Animal Health and BioLife Solutions
NASDAQ · 02/03 17:02
Silver Economy Boom: Investing in Healthcare's Aging Tailwinds
NASDAQ · 02/03 16:18
4 Medical Product Stocks to Watch From a Challenging Industry (Revised)
NASDAQ · 02/03 10:37
Morgan Stanley Remains a Buy on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)
TipRanks · 02/03 05:06
More
Webull provides a variety of real-time RMD stock news. You can receive the latest news about Resmed through multiple platforms. This information may help you make smarter investment decisions.
About RMD
ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.